ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 562 filers reported holding ASTRAZENECA PLC in Q3 2019. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $487,827 | +117.5% | 6,255 | +88.9% | 0.00% | – |
Q1 2024 | $224,320 | -99.8% | 3,311 | -99.8% | 0.00% | -100.0% |
Q2 2022 | $112,298,000 | -0.6% | 1,699,687 | -0.2% | 0.11% | +27.4% |
Q1 2022 | $112,936,000 | +54.4% | 1,702,372 | +35.6% | 0.08% | +68.0% |
Q4 2021 | $73,123,000 | -4.2% | 1,255,337 | -1.2% | 0.05% | -15.3% |
Q3 2021 | $76,310,000 | +27.5% | 1,270,565 | +27.2% | 0.06% | +18.0% |
Q2 2021 | $59,839,000 | -22.0% | 998,982 | -35.3% | 0.05% | -32.4% |
Q1 2021 | $76,761,000 | -2.0% | 1,543,856 | -1.5% | 0.07% | -3.9% |
Q4 2020 | $78,340,000 | -9.7% | 1,567,116 | -1.0% | 0.08% | -23.8% |
Q3 2020 | $86,783,000 | +4.2% | 1,583,635 | +0.5% | 0.10% | +5.2% |
Q2 2020 | $83,318,000 | +18.2% | 1,575,308 | -0.2% | 0.10% | +2.1% |
Q1 2020 | $70,471,000 | -19.9% | 1,577,949 | -10.5% | 0.09% | +17.5% |
Q4 2019 | $87,927,000 | +6.3% | 1,763,476 | -4.9% | 0.08% | -1.2% |
Q3 2019 | $82,688,000 | +293.1% | 1,855,231 | +264.1% | 0.08% | +305.0% |
Q2 2019 | $21,037,000 | +14.5% | 509,605 | +12.2% | 0.02% | +11.1% |
Q1 2019 | $18,369,000 | +58.1% | 454,332 | +48.5% | 0.02% | +38.5% |
Q4 2018 | $11,619,000 | -4.0% | 305,922 | -0.0% | 0.01% | +18.2% |
Q3 2018 | $12,109,000 | +273.2% | 306,020 | +231.1% | 0.01% | +266.7% |
Q2 2018 | $3,245,000 | +1.1% | 92,415 | +0.7% | 0.00% | 0.0% |
Q1 2018 | $3,211,000 | -4.0% | 91,815 | -4.8% | 0.00% | 0.0% |
Q4 2017 | $3,345,000 | +26.4% | 96,395 | +23.4% | 0.00% | +50.0% |
Q3 2017 | $2,646,000 | -37.7% | 78,098 | -37.3% | 0.00% | -50.0% |
Q2 2017 | $4,248,000 | -40.1% | 124,623 | -45.3% | 0.00% | -42.9% |
Q1 2017 | $7,095,000 | -12.9% | 227,854 | -23.5% | 0.01% | 0.0% |
Q4 2016 | $8,142,000 | +39.0% | 298,008 | +68.1% | 0.01% | +16.7% |
Q3 2016 | $5,858,000 | -11.1% | 177,234 | -18.8% | 0.01% | -14.3% |
Q2 2016 | $6,588,000 | -7.2% | 218,227 | -13.4% | 0.01% | -12.5% |
Q1 2016 | $7,099,000 | +25.8% | 252,112 | +51.7% | 0.01% | +33.3% |
Q4 2015 | $5,641,000 | -24.8% | 166,152 | +58.2% | 0.01% | -33.3% |
Q3 2014 | $7,502,000 | -4.0% | 105,014 | -0.1% | 0.01% | -10.0% |
Q2 2014 | $7,813,000 | -98.6% | 105,140 | -98.8% | 0.01% | -98.5% |
Q1 2014 | $564,421,000 | -8.7% | 8,699,468 | -16.4% | 0.68% | -13.9% |
Q4 2013 | $618,130,000 | +11.2% | 10,411,483 | -2.7% | 0.79% | +7.1% |
Q3 2013 | $555,913,000 | -8.5% | 10,705,041 | -16.6% | 0.74% | -14.7% |
Q2 2013 | $607,479,000 | – | 12,843,122 | – | 0.86% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |